Geoffrey Race - Jul 29, 2022 Form 4 Insider Report for F-star Therapeutics, Inc. (FSTX)

Role
Director
Signature
/s/ Darlene Deptula-Hicks, Attorney-in-fact
Stock symbol
FSTX
Transactions as of
Jul 29, 2022
Transactions value $
$433
Form type
4
Date filed
1/9/2023, 03:04 PM
Previous filing
Jun 22, 2022
Next filing
Mar 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FSTX Common Stock Options Exercise $433 +3.94K $0.11* 3.94K Jul 29, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FSTX Stock Option (right to buy) Options Exercise $0 -3.94K -50% $0.00 3.94K Jul 29, 2022 Common Stock 3.94K $0.11 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Report is reporting the exempt exercise of employee stock options for cash payment thereof and receipt of the resulting shares. No shares were sold incidental to the exercise of these stock options.
F2 This exercise price was originally reported incorrectly as $0.08 per share due to a conversion rate error from Pound Sterling into U.S. Dollars. Using the August 2022 approximate exchange rate of 1.2211, the exercise price in U.S. Dollars would be approximately $0.11 per share.
F3 Shall vest in 12 equal monthly installments so long as he remains a director of the company.